T
Trialingo operates a digital platform designed to match non-English speaking cancer patients with relevant clinical trials. The service provides multilingual support, personalized trial listings, and educational resources to facilitate informed participation. This approach aims to increase accessibility to breakthrough cancer treatments for diverse patient populations.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Trialingo operates a digital platform designed to match non-English speaking cancer patients with relevant clinical trials. The service provides multilingual support and educational resources to facilitate informed participation in groundbreaking treatment studies. This approach aims to increase accessibility to advanced oncology therapies for diverse patient populations.